caa a22 4500 445311436 CHVBK 20180317142631.0 cr unu---uuuuu 170323e20110801xx s 000 0 eng 10.1007/s00404-011-1878-x doi (NATIONALLICENCE)springer-10.1007/s00404-011-1878-x Hormone therapy in perimenopause and postmenopause (HT) [Elektronische Daten] Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version [Olaf Ortmann, Martina Dören, Eberhard Windler] This short version of the interdisciplinary S3 guideline on hormone therapy in peri- and postmenopause (HT) is intended as a decision-making instrument for physicians and women considering HT. It is designed to assist daily practice. This short version summarises the long version that contains detailed information about the development of the guideline, particularly about establishing the evidence levels. The statements and recommendations, quoted completely, are marked with the relevant levels of evidence (LoE) and grades of recommendation. The classification system from the Centre for Evidence-based Medicine in Oxford was used in this guideline (see "Attachment”). The Author(s), 2011 Hormone therapy nationallicence Perimenopause nationallicence Postmenopause nationallicence Risk communication nationallicence HT : Hormone therapy in the perimenopause and postmenopause nationallicence ET : Estrogen therapy nationallicence EPT : Estrogen-progestin therapy nationallicence LoE : Level of evidence nationallicence WHI : Women's Health Initiative nationallicence HERS : Heart and Estrogen/Progestin Replacement Study nationallicence VTE : Venous thromboembolism nationallicence CPA : Cyproterone acetate nationallicence CMA : Chlormadinon acetate nationallicence DNG : Dienogest nationallicence DRSP : Drospirenone nationallicence WHIMS : The Women's Health Initiative Memory Study nationallicence CEE : Conjugated equine estrogens nationallicence MPA : Medroxyprogesterone acetate nationallicence SSRI : Selective serotonine reuptake inhibitor nationallicence Ortmann Olaf Department of Gynaecology and Obstetrics, University of Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany aut Dören Martina Chair of Women's Health and Osteology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany aut Windler Eberhard Endocrinology and Metabolism of Ageing, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Haus N36, 20246, Hamburg, Germany aut Archives of Gynecology and Obstetrics Springer-Verlag 284/2(2011-08-01), 343-355 0932-0067 284:2<343 2011 284 404 https://doi.org/10.1007/s00404-011-1878-x text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00404-011-1878-x text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Ortmann Olaf Department of Gynaecology and Obstetrics, University of Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany aut NATIONALLICENCE 700 1- Dören Martina Chair of Women's Health and Osteology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany aut NATIONALLICENCE 700 1- Windler Eberhard Endocrinology and Metabolism of Ageing, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Haus N36, 20246, Hamburg, Germany aut NATIONALLICENCE 773 0- Archives of Gynecology and Obstetrics Springer-Verlag 284/2(2011-08-01), 343-355 0932-0067 284:2<343 2011 284 404 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer